Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of dermatological science (Amsterdam)

• Publication date

  2017-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jdermsci.2016.12.006PMID 27955882
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Genome Wide Study of Copy Number Variation Associated with Nasopharyngeal Carcinoma in Malaysian Chinese Identifies CNVs at 11q14.3 and 6p21.3 as Candidate Loci

  2016cited by this paper
• Management of side effects of immune checkpoint blockade by anti‐CTLA‐4 and anti‐PD‐1 antibodies in metastatic melanoma

  2016cited by this paper
• Checkpoint Blockade for the Treatment of Advanced Melanoma.

  2016cited by this paper
• Molecular stratification of metastatic melanoma using gene expression profiling : Prediction of survival outcome and benefit from molecular targeted therapy

  2015cited by this paper
• The landscape of long noncoding RNAs in the human transcriptome

  2015cited by this paper
• Genomic Classification of Cutaneous Melanoma.

  2015cited by this paper
• Long non-coding RNA HOTTIP is up-regulated and associated with poor prognosis in patients with osteosarcoma.

  2015cited by this paper
• Cancer Immunotherapy: A Future Paradigm Shift in the Treatment of Non–Small Cell Lung Cancer

  2015cited by this paper
• Intravenous high‐dose interferon with or without maintenance treatment in melanoma at high risk of recurrence: meta‐analysis of three trials

  2015cited by this paper
• Altered expression of long non-coding RNAs during genotoxic stress-induced cell death in human glioma cells

  2015cited by this paper
• Diminished levels of the soluble form of RAGE are related to poor survival in malignant melanoma

  2015cited by this paper
• The CASC15 long intergenic non-coding RNA locus is involved in melanoma progression and phenotype-switching

  2015cited by this paper
• Late Onset Ipilimumab-Induced Pericarditis and Pericardial Effusion: A Rare but Life Threatening Complication

  2015cited by this paper
• Comprehensive analysis of lncRNA-mRNA co-expression patterns identifies immune-associated lncRNA biomarkers in ovarian cancer malignant progression

  2015cited by this paper
• The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge

  2015cited by this paper
• Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor prognosis

  2015cited by this paper
• Long non-coding RNAs in colorectal cancer

  2015cited by this paper
• Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma

  2015cited by this paper
• Nivolumab: Immunotherapy in Malignant Melanoma.

  2015cited by this paper
• Correction: Long Non-Coding RNA BANCR Promotes Proliferation in Malignant Melanoma by Regulating MAPK Pathway Activation

  2015cited by this paper
• [Drug therapy of melanoma: anti-CTLA-4 and anti-PD-1 antibodies].

  2014cited by this paper
• Long non-coding RNAs drive metastatic progression in melanoma (Review).

  2014cited by this paper
• The Functional Characterization of Long Noncoding RNA SPRY4-IT1 in Human Melanoma Cells

  2014cited by this paper
• Southwest Oncology Group S0008: a phase III trial of high-dose interferon Alfa-2b versus cisplatin, vinblastine, and dacarbazine, plus interleukin-2 and interferon in patients with high-risk melanoma--an intergroup study of cancer and leukemia Group B, Children's Oncology Group, Eastern Cooperative

  2014cited by this paper
• Circulating miR-221 Expression Level and Prognosis of Cutaneous Malignant Melanoma

  2014cited by this paper
• Long Non-Coding RNA BANCR Promotes Proliferation in Malignant Melanoma by Regulating MAPK Pathway Activation

  2014cited by this paper
• EGFR and cyclin D1 in nodular melanoma: correlation with pathohistological parameters and overall survival

  2014cited by this paper
• Prognostic significance of KAI1/CD82 in human melanoma and its role in cell migration and invasion through the regulation of ING4.

  2014cited by this paper
• Prognostic significance of Fbw7 in human melanoma and its role in cell migration.

  2013cited by this paper
• Risk Factors for the Development of Locoregional Cutaneous Metastases as the Sole Form of Recurrence in Patients With Melanoma

  2013cited by this paper
• Risk factors for the development of locoregional cutaneous metastases as the sole form of recurrence in patients with melanoma.

  2013cited by this paper
• Progress and potential of immune checkpoint blockade for treating advanced renal cell carcinoma.

  2013cited by this paper
• A nine-gene signature predicting clinical outcome in cutaneous melanoma

  2013cited by this paper
• An update on risk factors, prognosis and management of melanoma patients.

  2012cited by this paper
• Role of Tip60 in human melanoma cell migration, metastasis, and patient survival.

  2012cited by this paper
• MMP2 expression is a prognostic marker for primary melanoma patients

  2012cited by this paper
• Global cancer statistics

  2011cited by this paper
• Melanoma MicroRNA Signature Predicts Post-Recurrence Survival

  2010cited by this paper
• Your patient with melanoma: staging, prognosis, and treatment.

  2009cited by this paper
• When hospice is the best option: an opportunity to redefine goals.

  2009cited by this paper
• Final version of 2009 AJCC melanoma staging and classification.

  2009cited by this paper
• Sentinel node biopsy or nodal observation

  2007cited by this paper
• Sentinel-node biopsy or nodal observation in melanoma.

  2007cited by this paper
• Sentinel-node biopsy or nodal observation in melanoma.

  2006cited by this paper
• Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials.

  2003cited by this paper
• Revised American Joint Committee on Cancer Staging Criteria Accurately Predict Sentinel Lymph Node Positivity in Clinically Node-Negative Melanoma Patients

  2003cited by this paper
• Survival estimation and testing via multiple imputation

  2002cited by this paper
• Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma.

  2001cited by this paper
• Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.

  2001cited by this paper
• Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm)

  2000cited by this paper
• Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial.

  2000cited by this paper
• Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker

  2000cited by this paper
• Toxicity of adjuvant high-dose interferon-alpha-2b in patients with cutaneous melanoma at high risk of recurrence.

  1999cited by this paper
• [Survival analysis in patients with cutaneous malignant melanoma].

  1997cited by this paper
• Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

  1996cited by this paper
• Natural history and selective management of in transit melanoma

  1990cited by this paper
• Model predicting survival in stage I melanoma based on tumor progression.

  1989cited by this paper
• Nonparametric estimation of lifetime and disease onset distributions from incomplete observations.

  1982cited by this paper
• Treatment for melanoma of the lower extremity with intralesional injection of bacille Calmette Guérin and hyperthermic perfusion.

  1979cited by this paper
• Evaluation of survival data and two new rank order statistics arising in its consideration.

  1966cited by this paper

• Fer-1 like family member 4 pseudogene: novel potential diagnostic and prognostic biomarker for cutaneous melanoma

  2024cites this paper
• Personalized Treatment Strategies via Integration of Gene Expression Biomarkers in Molecular Profiling of Laryngeal Cancer

  2024cites this paper
• Noncoding RNA circuitry in melanoma onset, plasticity, and therapeutic response.

  2023cites this paper
• Regulatory miRNAs and lncRNAs in Skin Cancer: A Narrative Review

  2023cites this paper
• Identification and validation of an epithelial mesenchymal transition-related gene pairs signature for prediction of overall survival in patients with skin cutaneous melanoma

  2022cites this paper
• A novel 7 RNA-based signature for prediction of prognosis and therapeutic responses of wild-type BRAF cutaneous melanoma

  2022cites this paper
• Long non-coding RNAs and melanoma: From diagnosis to therapy.

  2022cites this paper
• Long Non-Coding RNA CD27-AS1-208 Facilitates Melanoma Progression by Activating STAT3 Pathway

  2022cites this paper
• The Identification and Validation of a Robust Immune-Associated Gene Signature in Cutaneous Melanoma

  2021cites this paper
• ROS as Regulators of Cellular Processes in Melanoma

  2021cites this paper
• Integrative Predictive Modeling of Metastasis in Melanoma Cancer Based on MicroRNA, mRNA, and DNA Methylation Data

  2021cites this paper
• Epigenetic Landscape Analysis of the Long Non-Coding RNA and Messenger RNA in a Mouse Model of Corneal Alkali Burns

  2021cites this paper
• Comprehensive Review on the Clinical Relevance of Long Non-Coding RNAs in Cutaneous Melanoma

  2021cites this paper
• Role of non-coding RNAs in the progression and resistance of cutaneous malignancies and autoimmune diseases.

  2020cites this paper
• A novel RNA sequencing-based prognostic nomogram to predict survival for patients with cutaneous melanoma

  2020influential citation
• Predicting the Risk of Melanoma Metastasis Using an Immune Risk Score in the Melanoma Cohort

  2020cites this paper
• Melanoma: clinical-pathological and molecular analysis in patients of Ibague city, Colombia

  2020cites this paper
• An Immune-related lncRNAs Model for Prognostic of SKCM Patients Base on Cox Regression and Coexpression Analysis

  2020cites this paper
• The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma.

  2020cites this paper
• An immune risk score with potential implications in prognosis and immunotherapy of metastatic melanoma.

  2020cites this paper
• Predicting the clinical outcome of melanoma using an immune-related gene pairs signature

  2020cites this paper
• Observed Survival Interval: A Supplement to TCGA Pan-Cancer Clinical Data Resource

  2019cites this paper
• Long Non-Coding RNA-CASC15 Promotes Cell Proliferation, Migration, and Invasion by Activating Wnt/β-Catenin Signaling Pathway in Melanoma

  2019cites this paper
• Gene Signatures in Cutaneous Malignancies

  2019cites this paper
• Comprehensive Analysis of a Competing Endogenous RNA Network Identifies Seven-lncRNA Signature as a Prognostic Biomarker for Melanoma

  2019cites this paper
• Melanoma: clinic-pathological and molecular analyses in patients from Ibague, Colombia Melanoma: análisis clínico-patológico y molecular en pacientes de la ciudad de Ibagué, Colombia

  2019cites this paper
• Long noncoding RNA HCP5 suppresses skin cutaneous melanoma development by regulating RARRES3 gene expression via sponging miR-12

  2019cites this paper
• A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs

  2019cites this paper
• A four-DNA methylation biomarker is a superior predictor of survival of patients with cutaneous melanoma

  2019cites this paper
• A Panel of 12-lncRNA Signature Predicts Survival of Pancreatic Adenocarcinoma

  2019cites this paper
• Transcription Factor and lncRNA Regulatory Networks Identify Key Elements in Lung Adenocarcinoma

  2018cites this paper
• Interplay between small and long non‐coding RNAs in cutaneous melanoma: a complex jigsaw puzzle with missing pieces

  2018cites this paper
• Cofilin-1 levels and intracellular localization are associated with melanoma prognosis in a cohort of patients

  2018cites this paper
• A six-long non-coding RNA signature predicts prognosis in melanoma patients

  2018cites this paper
• Integrative analysis of competing endogenous RNA network focusing on long noncoding RNA associated with progression of cutaneous melanoma

  2018cites this paper
• Long noncoding RNA ILF3-AS1 promotes cell proliferation, migration, and invasion via negatively regulating miR-200b/a/429 in melanoma

  2017cites this paper